Vanguard Group Inc Emergent Bio Solutions Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,584,213 shares of EBS stock, worth $31.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,584,213

Previous 3,214,003 11.52%

Holding current value

$31.9 Million

Previous $15.6 Million 46.4%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$4.26 - $6.94 $1.58 Million - $2.57 Million	370,210 Added 11.52%	3,584,213 $22.9 Million
Q1 2025 May 09, 2025	BUY	$4.66 - $11.66 $61,991 - $155,112	13,303 Added 0.42%	3,214,003 $15.6 Million
Q4 2024 Feb 11, 2025	SELL	$7.72 - $11.97 $1.52 Million - $2.36 Million	-196,926 Reduced 5.8%	3,200,700 $30.6 Million
Q3 2024 Nov 13, 2024	SELL	$5.72 - $14.77 $1.54 Million - $3.97 Million	-268,608 Reduced 7.33%	3,397,626 $28.4 Million
Q2 2024 Aug 13, 2024	BUY	$1.86 - $6.98 $473,714 - $1.78 Million	254,685 Added 7.47%	3,666,234 $25 Million
Q1 2024 May 10, 2024	BUY	$1.5 - $3.41 $655,366 - $1.49 Million	436,911 Added 14.69%	3,411,549 $8.63 Million
Q4 2023 Feb 14, 2024	BUY	$1.82 - $3.16 $597,455 - $1.04 Million	328,272 Added 12.4%	2,974,638 $7.14 Million
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $5.38 Million - $13.4 Million	-1,695,976 Reduced 39.06%	2,646,366 $9 Million
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $8.01 Million - $14.4 Million	-1,090,283 Reduced 20.07%	4,342,342 $31.9 Million
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $205,274 - $429,257	26,351 Added 0.49%	5,432,625 $56.3 Million
Q4 2022 Feb 10, 2023	BUY	$11.0 - $21.45 $2.36 Million - $4.61 Million	214,788 Added 4.14%	5,406,274 $63.8 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $2.03 Million - $3.62 Million	101,059 Added 1.99%	5,191,486 $109 Million
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $1.81 Million - $2.88 Million	-65,954 Reduced 1.28%	5,090,427 $158 Million
Q1 2022 May 13, 2022	SELL	$36.48 - $52.22 $7.5 Million - $10.7 Million	-205,650 Reduced 3.84%	5,156,381 $212 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $14.6 Million - $24.2 Million	440,316 Added 8.95%	5,362,031 $233 Million
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $1.87 Million - $2.47 Million	-37,332 Reduced 0.75%	4,921,715 $246 Million
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $281 Million - $399 Million	4,959,047 New	4,959,047 $312 Million

Others Institutions Holding EBS

# of Institutions

188

Shares Held

39.4M

Call Options Held

299K

Put Options Held

157K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $444M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Emergent Bio Solutions Inc. Transaction History